Marijuana, Inc. (MAJI)
0.0065
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Marijuana Enterprise Value : -13.91M for Sept. 2, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 02, 2026 | -13.91M |
| September 01, 2026 | -13.90M |
| August 31, 2026 | -13.91M |
| August 28, 2026 | -13.91M |
| August 27, 2026 | -13.86M |
| August 26, 2026 | -13.87M |
| August 25, 2026 | -13.87M |
| August 24, 2026 | -13.91M |
| August 21, 2026 | -13.89M |
| August 20, 2026 | -13.83M |
| August 19, 2026 | -13.79M |
| August 18, 2026 | -13.80M |
| August 17, 2026 | -13.76M |
| August 14, 2026 | -13.78M |
| August 13, 2026 | -13.82M |
| August 12, 2026 | -13.77M |
| August 11, 2026 | -13.79M |
| August 10, 2026 | -13.74M |
| August 07, 2026 | -13.75M |
| August 06, 2026 | -13.74M |
| August 05, 2026 | -13.76M |
| August 04, 2026 | -13.77M |
| August 03, 2026 | -13.77M |
| July 31, 2026 | -13.82M |
| July 30, 2026 | -13.85M |
| Date | Value |
|---|---|
| July 29, 2026 | -13.85M |
| July 28, 2026 | -13.80M |
| July 27, 2026 | -13.80M |
| July 24, 2026 | -13.73M |
| July 23, 2026 | -13.65M |
| July 22, 2026 | -13.67M |
| July 21, 2026 | -13.85M |
| July 20, 2026 | -14.01M |
| July 17, 2026 | -14.00M |
| July 16, 2026 | -13.96M |
| July 15, 2026 | -13.93M |
| July 14, 2026 | -13.90M |
| July 13, 2026 | -13.90M |
| July 10, 2026 | -13.96M |
| July 09, 2026 | -13.94M |
| July 08, 2026 | -13.96M |
| July 07, 2026 | -13.91M |
| July 06, 2026 | -13.83M |
| July 02, 2026 | -13.78M |
| July 01, 2026 | -13.77M |
| June 30, 2026 | -13.86M |
| June 29, 2026 | -13.85M |
| June 26, 2026 | -13.88M |
| June 25, 2026 | -13.90M |
| June 24, 2026 | -13.90M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 404.09M |
| BioRestorative Therapies, Inc. | 1.582M |
| Astrana Health, Inc. | 2.244B |
| U.S. Stem Cell, Inc. | -- |
| CareDx, Inc. | 2.199B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.2711M |
| Total Expenses (Quarterly) | 0.2711M |
| EPS Diluted (Quarterly) | -0.0046 |
| Earnings Yield | -226.2% |
| Normalized Earnings Yield | -226.15 |